Acute oxidant damage promoted on cancer cells by amitriptyline in comparison with some common chemotherapeutic drugs

作者：David Cordero Mario; Antonio Sanchez Alcazar Jose; Rosa Bautista Ferrufino Maria; Ines Carmona Lopez Maria; Illanes Matilde; Jose Rios Maria; Garrido Maraver Juan; Alcudia Ana; Navas Placido; de Miguel Manuel^*

来源：Anti-Cancer Drugs, 2010, 21(10): 932-944.

DOI：10.1097/CAD.0b013e32833ed5f7

• amitriptyline
• anticancer
• chemotherapeutic drugs
• mitochondrial damage
• oxidative stress
• oxidation therapy
• reactive oxygen species

Oxidative therapy is a relatively new anticancer strategy based on the induction of high levels of oxidative stress, achieved by increasing intracellular reactive oxygen species (ROS) and/or by depleting the protective antioxidant machinery of tumor cells. We focused our investigations on the antitumoral potential of amitriptyline in three human tumor cell lines: H460 (lung cancer), HeLa (cervical cancer), and HepG2 (hepatoma); comparing the cytotoxic effect of amitriptyline with three commonly used chemotherapeutic drugs: camptothecin, doxorubicin, and methotrexate. We evaluated apoptosis, ROS production, mitochondrial mass and activity, and antioxidant defenses of tumor cells. Our results show that amitriptyline produces the highest cellular damage, inducing high levels of ROS followed by irreversible serious mitochondrial damage. Interestingly, an unexpected decrease in antioxidant machinery was observed only for amitriptyline. In conclusion, based on the capacity of generating ROS and inhibiting antioxidants in tumor cells, amitriptyline emerges as a promising new drug to be tested for anticancer therapy.

• 出版日期2010-11